ImmunologybioRxivPreprint
Engagement of sialylated glycans with Siglec receptors on myeloid suppressor cells inhibit anti-cancer immunity via CCL2
R. Wieboldt, E. Carlini, L. Chia-wei…·N. Rodrigues Mantuano
This study shows that sialylated glycans on myeloid suppressor cells interact with Siglec receptors to suppress anti-cancer immunity through CCL2-mediated mechanisms.
DOI 10.1101/2023.06.29.547025